In ₹ Crore except Per Share Latest Annual | SOLARA FY26 | INDSWFTLAB FY26 | DCAL FY26 | SMSPHARMA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | 76.57× | ◆ 26.88× | 37.31× | 37.31× | |
| P/B | 2.50× | 2.38× | ◆ 0.39× | 4.96× | 2.38× +5% | |
| EV/EBITDA | 20.34× | 63.58× | ◆ 8.12× | 24.61× | 24.61× -17% | |
| Market Cap | ₹3,142 Cr | ₹3,291 Cr | ₹2,621 Cr | ₹3,896 Cr | ₹3,291 Cr -5% | |
| Growth | ||||||
| Revenue CAGR 3Y | -1.76% | -19.01% | 6.71% | ◆ 19.32% | 6.71% -126% | |
| Revenue CAGR 5Y | -3.27% | — | 8.93% | ◆ 9.51% | 9.22% -135% | |
| Net Income CAGR 3Y | — | -4.53% | — | — | -4.53% | |
| Revenue YoY (latest Q) | 19.57% | ◆ 25.35% | -4.29% | 5.57% | 5.57% +251% | |
| Net Income YoY (latest Q) | 55.04% | ◆ 181.32% | -347.24% | 2.04% | 2.04% +2598% | |
| Profitability | ||||||
| EBITDA Margin | 13.64% | 7.03% | 19.29% | ◆ 19.31% | 19.29% -29% | |
| Net Income Margin | -0.54% | 6.46% | 3.32% | ◆ 11.50% | 6.46% -108% | |
| Return on Common Equity | -0.59% | 2.99% | 1.46% | ◆ 12.99% | 2.99% -120% | |
| Return on Capital Employed | 6.05% | 1.02% | 2.36% | ◆ 13.01% | 2.36% +156% | |
| Return on Assets | -0.32% | 2.47% | 0.82% | ◆ 7.49% | 2.47% -113% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.53× | ◆ 0.01× | 0.42× | 0.46× | 0.42× +26% | |
| Interest Coverage | 0.92× | ◆ 10.31× | 1.30× | 5.69× | 5.69× -84% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,369 Cr | ₹641 Cr | ₹2,932 Cr | ₹887 Cr | ₹887 Cr +54% | |
| Net Income | −₹7.4 Cr | ₹41.4 Cr | ₹97.5 Cr | ₹102 Cr | ₹97.5 Cr -108% | |
| Total Assets | ₹2,333 Cr | ₹1,673 Cr | ₹11,923 Cr | ₹1,362 Cr | ₹1,673 Cr +39% | |
| EPS | ₹-1.68 | ₹4.95 | ₹6.22 | ₹11.15 | ₹6.22 -127% | |
| Book Value per Share | ₹282.08 | ₹159.38 | ₹425.82 | ₹83.91 | ₹159.38 +77% | |